Zauatbayeva, G.M., L.R. Syzdykova, V.V. Keyer, A.V. Shustov, A.Z. Abilmagzhanov, and M.Zh. Zhurynov. “NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS”. Eurasian Journal of Applied Biotechnology, no. 2 (July 9, 2022): 44–53. Accessed November 24, 2024. https://biotechlink.org/index.php/journal/article/view/338.